These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36771360)

  • 1. Investigation of Enterogermina's Protective and Restorative Mechanisms on the Gut Microbiota with PPI, Using SHIME Technology.
    Duysburgh C; Verstrepen L; Broeck MVD; Righetto Z; Perez M
    Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of gastric acid suppression on probiotic colonization in a double blinded randomized clinical trial.
    Singh G; Haileselassie Y; Briscoe L; Bai L; Patel A; Sanjines E; Hendler S; Singh PK; Garud NR; Limketkai BN; Habtezion A
    Clin Nutr ESPEN; 2022 Feb; 47():70-77. PubMed ID: 35063245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitors enhance intestinal permeability via dysbiosis of gut microbiota under stressed conditions in mice.
    Takashima S; Tanaka F; Kawaguchi Y; Usui Y; Fujimoto K; Nadatani Y; Otani K; Hosomi S; Nagami Y; Kamata N; Taira K; Tanigawa T; Watanabe T; Imoto S; Uematsu S; Fujiwara Y
    Neurogastroenterol Motil; 2020 Jul; 32(7):e13841. PubMed ID: 32319196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiota Composition Before and After Use of Proton Pump Inhibitors.
    Hojo M; Asahara T; Nagahara A; Takeda T; Matsumoto K; Ueyama H; Matsumoto K; Asaoka D; Takahashi T; Nomoto K; Yamashiro Y; Watanabe S
    Dig Dis Sci; 2018 Nov; 63(11):2940-2949. PubMed ID: 29796911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitor-induced gut dysbiosis and immunomodulation: current knowledge and potential restoration by probiotics.
    Kiecka A; Szczepanik M
    Pharmacol Rep; 2023 Aug; 75(4):791-804. PubMed ID: 37142877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review: the effects of proton pump inhibitors on the microbiome of the digestive tract-evidence from next-generation sequencing studies.
    Macke L; Schulz C; Koletzko L; Malfertheiner P
    Aliment Pharmacol Ther; 2020 Mar; 51(5):505-526. PubMed ID: 31990420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of proton pump inhibitors on the microbiome in young children.
    Levy EI; Hoang DM; Vandenplas Y
    Acta Paediatr; 2020 Aug; 109(8):1531-1538. PubMed ID: 32027402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of proton pump inhibitor or rebamipide use on gut microbiota of rheumatoid arthritis patients.
    Kim JW; Jeong Y; Park SJ; Jin H; Lee J; Ju JH; Ji GE; Park SH
    Rheumatology (Oxford); 2021 Feb; 60(2):708-716. PubMed ID: 32789440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with a spore-based probiotic containing five strains of Bacillus induced changes in the metabolic activity and community composition of the gut microbiota in a SHIME® model of the human gastrointestinal system.
    Marzorati M; Van den Abbeele P; Bubeck S; Bayne T; Krishnan K; Young A
    Food Res Int; 2021 Nov; 149():110676. PubMed ID: 34600678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified.
    Bruno G; Zaccari P; Rocco G; Scalese G; Panetta C; Porowska B; Pontone S; Severi C
    World J Gastroenterol; 2019 Jun; 25(22):2706-2719. PubMed ID: 31235994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacillus clausii for Gastrointestinal Disorders: A Narrative Literature Review.
    Acosta-Rodríguez-Bueno CP; Abreu Y Abreu AT; Guarner F; Guno MJV; Pehlivanoğlu E; Perez M
    Adv Ther; 2022 Nov; 39(11):4854-4874. PubMed ID: 36018495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral microbiome alterations of healthy volunteers with proton pump inhibitor.
    Mishiro T; Oka K; Kuroki Y; Takahashi M; Tatsumi K; Saitoh T; Tobita H; Ishimura N; Sato S; Ishihara S; Sekine J; Wada K; Kinoshita Y
    J Gastroenterol Hepatol; 2018 May; 33(5):1059-1066. PubMed ID: 29105152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis.
    Horvath A; Rainer F; Bashir M; Leber B; Schmerboeck B; Klymiuk I; Groselj-Strele A; Durdevic M; Freedberg DE; Abrams JA; Fickert P; Stiegler P; Stadlbauer V
    Sci Rep; 2019 Aug; 9(1):12000. PubMed ID: 31427714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alkalihalobacillus clausii (formerly Bacillus clausii) spores lessen antibiotic-induced intestinal injury and reshape gut microbiota composition in mice.
    Pirozzi C; Opallo N; Coretti L; Lama A; Annunziata C; Comella F; Melini S; Buommino E; Mollica MP; Aviello G; Mattace Raso G; Lembo F; Meli R
    Biomed Pharmacother; 2023 Jul; 163():114860. PubMed ID: 37196540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotic infant cereal improves children's gut microbiota: Insights using the Simulator of Human Intestinal Microbial Ecosystem (SHIME®).
    Salgaço MK; Perina NP; Tomé TM; Mosquera EMB; Lazarini T; Sartoratto A; Sivieri K
    Food Res Int; 2021 May; 143():110292. PubMed ID: 33992391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of non-antibiotic drugs on the human intestinal microbiome.
    Le Bastard Q; Berthelot L; Soulillou JP; Montassier E
    Expert Rev Mol Diagn; 2021 Sep; 21(9):911-924. PubMed ID: 34225544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in Cirrhosis.
    Bajaj JS; Acharya C; Fagan A; White MB; Gavis E; Heuman DM; Hylemon PB; Fuchs M; Puri P; Schubert ML; Sanyal AJ; Sterling RK; Stravitz TR; Siddiqui MS; Luketic V; Lee H; Sikaroodi M; Gillevet PM
    Am J Gastroenterol; 2018 Aug; 113(8):1177-1186. PubMed ID: 29872220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compared to histamine-2 receptor antagonist, proton pump inhibitor induces stronger oral-to-gut microbial transmission and gut microbiome alterations: a randomised controlled trial.
    Zhu J; Sun C; Li M; Hu G; Zhao XM; Chen WH
    Gut; 2024 Jun; 73(7):1087-1097. PubMed ID: 38050061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for proton-pump inhibitor (PPI)-associated dysbiosis in metabolically unhealthy obesity.
    Burmeister MA; Smith TE; Fincher TK; Weldon AJ
    Front Endocrinol (Lausanne); 2023; 14():1205490. PubMed ID: 37396171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duodenal Dysbiosis and Relation to the Efficacy of Proton Pump Inhibitors in Functional Dyspepsia.
    Wauters L; Tito RY; Ceulemans M; Lambaerts M; Accarie A; Rymenans L; Verspecht C; Toth J; Mols R; Augustijns P; Tack J; Vanuytsel T; Raes J
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.